Surmodics Inc at Needham Healthcare Conference Transcript
Pleased to introduce Gary Maharaj, CEO of Surmodics. He's going to give a talk on the company and we may have some time for questions at the end.
Absolutely. And what I'm about to tell you today, and really, those of you who followed Surmodics know a little bit about us, we have a vision, a very bold vision of having 3 of the top 10 innovations in vascular medicine in a very short period of time. And really, what we're looking at initially are peripheral artery disease and impact to patients, but for Tim and I, our CFO, we're looking at growth and return on invested capital. And we manage each of those very distinctively. We don't try to chase growth at all costs but we also understand the investments required for growth.
So big, bold statement, by 2020, how we're going to get there. And clearly, you know the issues involved with peripheral arterial disease. These are very low numbers and it's endemic in both emerging countries and emerging populations.
What we'll
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
